[1] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
[2] |
YE Hongbo, SONG Yangyang, XUE Ling, RUI Jianzhong.
Meropenem population pharmacokinetic model for the Chinese elderly established by model-based META analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 984-990.
|
[3] |
LIU Wei, XUE Junsheng, YU Zhiheng, WANG Ziyu, CHEN Rong, ZHOU Tianyan.
Interpretation of pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer guidance for industry
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 86-94.
|
[4] |
GAO Lili, CHEN Rui, LI Lujin, ZHENG Qingshan .
Dose selection of obeticholic acid in hepatic impairment patients and the review consideration of FDA
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 760-767.
|
[5] |
SUN Bo, FU Shujun, CHEN Guiliang, LI Li.
Applications of Drug Interaction Study in New Drug Development and Regulartory Decision-making
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1095-1102.
|
[6] |
ZHANG Yulong, ZHAO Ying, ZHANG Wei.
Application of pharmacomicrobiomics in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 58-64.
|
[7] |
LI Jian, YAN Fang, YANG Jinbo, WANG Yuzhu.
Application of model-informed drug development approach in dose optimization: Insights from the modification of nivolumab dosage regimen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 408-412.
|
[8] |
CHEN Wenjun, RUAN Zourong, XIANG Xiaoqiang.
Development and application progress of physiologically based pharmacokinetic modeling and its combined use with other modeling methods
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 299-305.
|
[9] |
LI Jian, YANG Jinbo, WANG Yuzhu.
Applications of model-informed drug development (MIDD) on new drug research and development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 1-8.
|
[10] |
YANG Jingmo, ZHANG Bo, SUN Yancai.
Review and economic analysis of preoperative antimicrobial application during the period of type I incision operation in a cancer hospital
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 821-825.
|
[11] |
MA Guangli, XU Ling, CHEN Rui, CHEN Yuancheng, ZHAO Wei, LIU Dongyang, JIAO Zheng, LI Jian, JI Shuangmin, LI Li, LI Liang, WANG Yuzhu, YANG Jinbo, WANG Yaning, SUN He, HU Pei, ZHENG Qingshan, LU Wei.
General considerations of population pharmacokinetic/pharmacodynamic study in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1201-1220.
|
[12] |
LIU Dongyang,WANG Kun,MA Guangli,XIANG Xiaoqiang,LIU Jiang,ZHAO Ping,CHEN Rui,CHEN Yuancheng,HUANG Xiaohui, LI Li,LI Lujin,NIE Jing,WANG Yuzhu,WEI Chunmin,LU Wei,SHI Jun, ZHENG Qingshan.
The value and general consideration of pharmacometric study in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 961-973.
|
[13] |
WANG Xin, CHEN Baoqiang, LI Hongyu.
Research progress of the key targets of autophagy and related drugs in mammalian cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 205-210.
|
[14] |
BU Ming-hua, ZHANG Ying , LIU Jian-xun , LIU Dong-chun.
Research approaches of CYP450s' induction/inhibition and their application on drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 579-585.
|
[15] |
ZHU Lei, ZHANG Li-fang, XU Lan, WANG Juan, ZHANG Guo-dong, SHEN Ming-feng.
Cost-effectiveness analysis of three treatment schemes for Insulin Aspart 30 Injection on type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1406-1409.
|